You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
聯環藥業(600513.SH):原料藥鹽酸多西環素生產線符合GMP要求
格隆匯 03-25 16:24

格隆匯3月25日丨聯環藥業(600513.SH)公佈,近日,公司從江蘇省藥品監督管理局網站獲悉藥品GMP符合性檢查結果公吿(2022年第26號)。檢查範圍:原料藥(鹽酸多西環素)(C7廠房北側五層、C7廠房北側三層14號精烘包);主要生產品種:原料藥鹽酸多西環素;設計產能:40000Kg/年。

公司該次原料藥GMP符合性檢查是生產場地變更後恢復性生產所增加的品種認證,原料藥鹽酸多西環素生產線(與其他品種共線)的投入約為人民幣2405萬元(未經審計)。

公司表示,其此次獲得藥品GMP符合性檢查結果,表明公司相關生產線符合GMP要求,將有利於公司繼續保持穩定的產品質量和持續穩定的生產能力,以滿足相關藥品的市場需求。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account